CASP3 and gastric cancer: Following lobaplatin treatment, these cells undergo PYR stimulated by the caspase 3-mediated cleavage of GSDM E. Similarly, in gastric cancer (GC) the levels of GSDM E are implemented by the exposure to 5-fluorouracil (5-FU).